UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033860
Receipt number R000038611
Scientific Title Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in suplaclavicular and interscalene brachial plexus block for pediatric postoperative analgesia.
Date of disclosure of the study information 2018/08/22
Last modified on 2018/08/22 20:32:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in suplaclavicular and interscalene brachial plexus block for pediatric postoperative analgesia.

Acronym

Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in suplaclavicular and interscalene brachial plexus block for pediatric postoperative analgesia.

Scientific Title

Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in suplaclavicular and interscalene brachial plexus block for pediatric postoperative analgesia.

Scientific Title:Acronym

Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in suplaclavicular and interscalene brachial plexus block for pediatric postoperative analgesia.

Region

Japan


Condition

Condition

Pediatric patients given brachial plexus block

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluating the hypothesis that adding dexamethasone to ropivacaine significantly prolongs the duration of analgesia in brachial plexus block compared with ropivacaine alone.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Presence or absence and strength of pain within 24 hours after surgery

Key secondary outcomes

The time until the analgesic drug is used for the first time, and the pain score at that time


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

control(ropivacaine only)

Interventions/Control_2

Add dexamethasone to ropivacaine

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

Pediatric patients undergoing elective upper limb surgeries using general anesthesia and echo guided brachial plexus block.

Key exclusion criteria

history of allergic reaction to study drugs, infection at brachial plexus block site

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tomoko Kotera

Organization

Osaka Saiseikai Nakatsu Hospital

Division name

Department of Anesthesia

Zip code


Address

2-10-39 Shibata Kitaku Osaka City

TEL

0663720333

Email

koolinaare@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Tomoko Kotera

Organization

Osaka Saiseikai Nakatsu Hospital

Division name

Department of Anesthesia

Zip code


Address

2-10-39 Shibata Kitaku Osaka City

TEL

0663720333

Homepage URL


Email

koolinaare@gmail.com


Sponsor or person

Institute

Aoki surgery orthopedic hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 08 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 05 Month 11 Day

Date of IRB


Anticipated trial start date

2016 Year 05 Month 11 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 08 Month 22 Day

Last modified on

2018 Year 08 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038611


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name